US Stocks Could Remain Jittery Thursday Over Fed Rate Hike As S&P 500, Nasdaq Futures See Volatility — McDonald’s In Focus
September 22, 7:23 AM
The major U.S. index futures are flatlining, as traders are digesting the implication of the Fed's policy statement and a couple of interest rate decisions from Japan and the United Kingdom.
GSK and Spero Therapeutics Announced Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr; Spero to Receive $66M Upfront Plus Potential Milestones Up to $375M
September 22, 4:53 AM
GSK (LSE/NYSE: GSK) and Spero Therapeutics, Inc. (Nasdaq: SPRO) today announced they have entered into an exclusive license agreement for Spero's late-stage antibiotic asset, tebipenem HBr.
September 20, 9:49 AM
Haleon PLC (NYSE:HLN) reported a strong performance in 1H of 2022 in its first earnings report since separating from GSK plc (NYSE:GSK) in…
September 20, 4:46 AM
Haleon has notified GSK and Pfizer that it rejects their requests for indemnification on the basis that the scope of the indemnities set out in the joint venture agreement only covers their consumer healthcare businesses as conducted when the JV was formed in 2018. At that time, neither GSK nor Pfizer marketed OTC Zantac in the US or Canada.
September 19, 2:28 PM
Theravance Biopharma Inc (NASDAQ:TBPH) is buying back over 9.6 million shares from GSK plc (NYSE:GSK) for roughly $94 million, according to an…
September 15, 9:27 AM
Pfizer Inc (NYSE:PFE) has announced topline results from the Phase 3 trial of its investigational pentavalent meningococcal vaccine (MenABCWY) in healthy…
September 12, 11:18 AM
AnaptysBio Inc (NASDAQ:ANAB), a clinical-stage biotechnology company focused on immunology therapeutics, has sold its royalty interest on future global…